Pyrimidine Synthesis Inhibitor
18 drugs across 9 manufacturers|18 Generic,0 Brand
The Pyrimidine Synthesis Inhibitor class contains 18 NDCs from 9 manufacturers (18 generic, 0 brand), at an average NADAC of $0.38 per unit. Every drug, manufacturer, and price in this FDA-defined pharmacologic class is listed below.
Total Drugs
18
18G / 0B
Manufacturers
9
Avg $0.3814/unit
Avg 7d Change
-12.56%
Across 16 drugs with changes
7d Activity
of 18 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Frequently Asked Questions
How many drugs are in the Pyrimidine Synthesis Inhibitor class?
The Pyrimidine Synthesis Inhibitor class contains 18 NDCs from 9 manufacturers — 18 generic and 0 brand products.
What is the average price of Pyrimidine Synthesis Inhibitor drugs?
The average NADAC for the Pyrimidine Synthesis Inhibitor class is $0.3814 per unit across 18 NDCs.
Which manufacturers make Pyrimidine Synthesis Inhibitor drugs?
9 manufacturers make drugs in the Pyrimidine Synthesis Inhibitor class. Ranked by number of NDCs, the largest are Accord Healthcare Inc. (2), Teva Pharmaceuticals USA Inc. (2), Camber Pharmaceuticals Inc. (2), Aurobindo Pharma Limited (2), Alembic Pharmaceuticals Inc. (2).
How has Pyrimidine Synthesis Inhibitor pricing changed recently?
Over the past 7 days, 0 NDCs in this class rose and 16 fell, with a class-wide average change of -12.6%.
Manufacturer Breakdown
9 manufacturers producing drugs in this therapeutic class(1 pricing outlier)